Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Clinics in Columbus, Cleveland, Dayton, and Cincinnati have lost their licenses to distribute dangerous drugs after the Ohio Board of Pharmacy said they were giving patients weight-loss drugs that ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

The liver and pancreas are the main actors in glucose metabolism, but not the only ones. Muscles, adipose tissue and the brain play different roles. However, the prize for the best new actor in ...

"Overall, metabolic responses to glucagon stimulation in individuals with type 1 diabetes are comparable to those in healthy ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The pharmaceutical industry came up with medicine that stops people from craving processed, addictive foods and the food industry is in a panic.

The following is a summary of “Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls,” published ...

GLP-1RA weight-loss drugs provide health benefits but also pose risks, including pancreatitis, kidney problems, and ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

SAINT JOHN, Ind. - A 40-year-old man who was fatally shot during an altercation with a St. John police officer on Wednesday has been identified. What we know: At approximately 11:30 a.m., St.